Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mechanisms And Prognosis of Stroke-Heart Syndrome

NCT06954103 is registered in ClinicalTrials.gov with Chensheng Pan as lead sponsor.

NCT NCT06954103
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06954103 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mechanisms And Prognosis of Stroke-Heart Syndrome
Lead sponsor
Chensheng Pan
Phase
Observational
Overall status
Recruiting
Start date
March 1, 2025
Completion date
April 1, 2028
Enrollment
658 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute coronary syndromes, arrhythmia, heart failure, heart rate variability, myocardial injury, stroke, sudden cardiac death, takotsubo syndrome